期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Toxicology Research LetPub Score 5.3
50 ratings
Rate
Reputation 6.4 Influence 3.9 Speed 7.6 | ||||||||||||||||||||
期刊簡稱 | TOXICOL RES-UK | ||||||||||||||||||||
ISSN | 2045-452X | ||||||||||||||||||||
E-ISSN | 2045-4538 | ||||||||||||||||||||
h-index | 24 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 4.50%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://academic.oup.com/toxres | ||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/tx | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Royal Society of Chemistry | ||||||||||||||||||||
主題領域 | TOXICOLOGY | ||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 119每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 9.71% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2045-452X%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Toxicology Research] 的評論 | 撰寫評論 |
作者: 桃花尔冬 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-10 09:09:40 評論於 Research Focus: Pharmacology; Traditional Chinese Medicine Experience Sharing: It has been a month and a half since submission, and it has been in the status of "Awaiting Reviewer Selection". What's going on?(0) 讚! | 桃花尔冬 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:38:31 評論於 We suggest breaking down the discussion of research limitations into three parts: (1) identifying the research limitations; (2) providing detailed explanations for the research limitations; and (3) proposing future research directions or improvement suggestions. Following this sequence to discuss research limitations can help you clearly present the shortcomings of the study without compromising its quality and validity(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:30:45 評論於 It is still necessary to clearly explain the limitations of the study in the paper and describe how these limitations may affect the conclusions of the paper, so that reviewers and other readers can understand that we have taken the limitations of the study into full consideration. Mentioning the limitations of the research work in the discussion section generally enhances the credibility of the article. Thinking about how to overcome these limitations in future research will have a positive effect(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 22:32:47 評論於 Do we need to specify the limitations of the article in the discussion?(0) 讚! | Oswald Edie |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 15:11:05 評論於 How to write about limitations in a discussion?(0) 讚! | 北国博达 |
作者: 奕剑正利 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-01-26 15:07:06 評論於 I was politely rejected by the chief editor of Toxicology Section 2 before, and then I switched to Toxicology Reports. The reviewer's questions were very professional and required major revisions, but AE Zhou gave me the opportunity, for which I am grateful. Although there were many changes and extra experiments were done, I feel that the quality of the article has significantly improved and I have also benefited a lot(0) 讚! | 奕剑正利 |
作者: 小马哈哈哈 領域: 医学 審稿時間: 8.0 month(s) 結果: 修改後接受 撰寫評論 |
2020-08-12 20:51:41 評論於 20191211 Submission; 20200102 Reviewer assigned; 20200326 Comments received; major revision required; 20200705 Revision submitted (affected by the epidemic); 20200708 Accept. (0) 讚! | 小马哈哈哈 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 22:31:44 評論於 It's annoying. Last year I got over 2 points, but this year only just over 1 point. Will it decrease even more next year? Who would want to invest in it?(0) 讚! | 凌霄高洁 |
作者: 猫巷少女淑惠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-03 18:03:49 評論於 May I ask, how much is the page fee? shuo@123 Posted on 2015-07-11: One was accepted, submitted on August 22 last year, received major revisions on September 17, revised on October 9, minor revisions on October 27, there was a problem in the middle, and it was not accepted until December 3. It took about 100 days, but the speed was still acceptable(0) 讚! | 猫巷少女淑惠 |
作者: 一条小毓珂 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-01-08 12:55:38 評論於 Hello, I would like to ask if there will still be an external review after the minor revisions(0) 讚! | 一条小毓珂 |
作者: 月河新芙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-09-20 17:23:05 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: 7.6 Submission 7.7 Under review 7.30 In peer review 8.11 Major Revision 9.4 Revision Submitted to Journal 9.6 In peer review 9.18 Accepted 9.19 online(0) 讚! | 月河新芙 |
作者: 蒙德文枝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-07-11 17:35:30 評論於 I won an article submission last year on August 22nd, received major revisions on September 17th, revised on October 9th, made minor revisions on October 27th, encountered some issues in between, and finally accepted on December 3rd. It was about 100 days in total, the speed was acceptable(0) 讚! | 蒙德文枝 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-30 21:14:29 評論於 Review speed: 3.0 | Submission hit rate: 50.0 Experience sharing: When the magazine was first launched, the boss received an invitation and therefore submitted my article on nanotoxicology here in early May 2013. It was rejected in mid-July with a lot of comments from two reviewers. However, upon closer inspection, some of the comments were quite constructive, while others seemed to be nitpicking. Later, I met an editor of the magazine who said that although the article had sufficient data, this journal required detailed analysis data on the nanomaterial for articles on nanotoxicity, whereas our article mainly focused on biological effects. The magazine, co-sponsored by the Chinese Society of Toxicology and the British Society of Toxicology, is published under the RSC and is a promising magazine. Moreover, color illustrations are free and there are no publication fees. There are many articles by Chinese authors in the magazine. With sufficient data and some novelty, it may be worth considering submitting an article. Of course, one must carefully read the article requirements and ensure that the necessary data is not lacking(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us